Year(s) | Type/Subtype | Study population | Mean GT/SIa | Reproduction number (R) | 95% CIb | Basic or effective | Case definition | Reference | Year published |
---|---|---|---|---|---|---|---|---|---|
1889–1890 | H3N8? | USA & Europe | 2.6 | 2.10 | 1.9–2.4 | Basic | Unconfirmed deaths | [101] | 2010 |
1948–1949 | H1N1 | Canada | 4.1 | 1.30 |  | Effective | Unconfirmed illness | [25] | 2006 |
1949–1950 | H1N1 | Canada | 4.1 | 1.50 |  | Effective | Unconfirmed illness | [25] | 2006 |
1950–1951 | H1N1 | Canada & UK | 4.1 | 2.00 | 1.9–2.5 | Effective | Unconfirmed deaths | [25] | 2006 |
1958–1973 | H2N2; H3N2; B | United Kingdom | 4.48 | 3.9–7.1 |  | Effective | Unconfirmed illness | [102] | 1979 |
1972–2002 | H1N1/H3N2/B | Australia | 5.5 | 1.30 |  | Effective | Unconfirmed deaths | [103] | 2008 |
1972–2002 | H1N1/H3N2/B | France | 5.5 | 1.30 |  | Effective | Unconfirmed deaths | [103] | 2008 |
1972–2002 | H1N1/H3N2/B | USA | 5.5 | 1.30 |  | Effective | Unconfirmed deaths | [103] | 2008 |
1972–2002 | H1N1/H3N2/B | USA; France; Australia | 5.5 | 1.30 | 1.2–1.4 | Effective | Unconfirmed deaths | [103] | 2008 |
1975–2004 | H1N1/H3N2/B | Norway | 6 | 1.06–1.69 |  | Effective | Unconfirmed deaths | [104] | 2010 |
1976–1981 | H1N1/H3N2/B | USA | 2.6 | 1.70 |  | Basic | Serology confirmed infection | [10] | 2006 |
1976–1981 | H1N1/H3N2/B | USA | 4.1 | 1.16 |  | Basic | Serology confirmed infection | [105] | 2000 |
1977–1978 | H1N1 | United Kingdom | 2.2 | 4.38 |  | Basic | Unconfirmed illness | [106] | 2005 |
1977–1978 | H1N1 | United Kingdom | 3 | 21.00 |  | Basic | Unconfirmed illness | [13] | 2004 |
1977–1978 | H1N1 | United Kingdom | 4.70 | 16.90 |  | Basic | Unconfirmed illness | [106] | 2005 |
1984–1985 | H1N1/H3N2 | France | 2.49 | 1.37 |  | Effective | Unconfirmed illness | [107] | 1988 |
1985–2005 | H1N1/H3N2/B | United Kingdom | 2.2 | 1.6–2.1 |  | Basic | Unconfirmed illness | [108] | 2010 |
1985–2005 | H1N1/H3N2/B | United Kingdom | 2.7 | 1.6–2.5 |  | Basic | Unconfirmed illness | [109] | 2012 |
1985–2006 | H1N1/H3N2/B | France | 2.4 | 1.4–1.7 | 1.3–1.8 | Basic | Unconfirmed illness | [110] | 2008 |
1996–2006 | H1N1/H3N2/B | Brazil | 3 | 1.03 | 1.02–1.04 | Effective | Unconfirmed deaths | [111] | 2010 |
1998–1999 | H3N2 | Israel | 3 | 1.14 |  | Effective | Unconfirmed illness | [112] | 2011 |
1998–1999 | H3N2 | Israel | 3 | 1.16 |  | Effective | Unconfirmed illness | [112] | 2011 |
1998–1999 | H3N2 | USA | 3 | 1.18 | 1.05–1.25 | Effective | Laboratory confirmed illness | [113] | 2009 |
1998–2009 | H1N1/H3N2/B | Israel | 2.5 | 1.17–1.62 |  | Effective | Unconfirmed illness | [114] | 2012 |
1999–2000 | H3N2 | Israel | 3 | 1.16 |  | Effective | Unconfirmed illness | [112] | 2011 |
1999–2000 | H3N2 | Israel | 3 | 1.18 |  | Effective | Unconfirmed illness | [112] | 2011 |
1999–2006 | Seasonal H1N1 | Taiwan | 2 | 1.19 | 0.76–1.86 | Basic | Confirmed and unconfirmed illness | [115] | 2010 |
1999–2006 | H3N2 | Taiwan | 3 | 1.41 | 0.92–2.19 | Basic | Confirmed and unconfirmed illness | [115] | 2010 |
1999–2006 | B | Taiwan | 3 | 1.07 | 0.69–1.69 | Basic | Confirmed and unconfirmed illness | [115] | 2010 |
2000–2001 | H1N1 | Israel | 3 | 1.12 |  | Effective | Unconfirmed illness | [112] | 2011 |
2000–2009 | H1N1/H3N2/B | Italy | 4 | 1.17–1.36 |  | Effective | Unconfirmed illness | [116] | 2012 |
2001–2002 | H3N2 | Israel | 3 | 1.25 |  | Effective | Unconfirmed illness | [112] | 2011 |
2001–2002 | H3N2 | Israel | 3 | 1.27 |  | Effective | Unconfirmed illness | [112] | 2011 |
2003–2004 | H3N2 | Israel | 3 | 1.19 |  | Effective | Unconfirmed illness | [112] | 2011 |
2003–2004 | H3N2 | Israel | 3 | 1.21 |  | Effective | Unconfirmed illness | [112] | 2011 |
2003–2004 | H3N2 | Switzerland | 2.6 | 1.2–1.3 |  | Effective | Unconfirmed illness | [117] | 2011 |
2004–2005 | H3N2 | Israel | 3 | 1.25 |  | Effective | Unconfirmed illness | [112] | 2011 |
2004–2005 | H3N2 | Israel | 3 | 1.25 |  | Effective | Unconfirmed illness | [112] | 2011 |
2004–2005 | unspecified | Taiwan | 4.1 | 1.00 |  | Effective | Unconfirmed deaths | [118] | 2010 |
2004–2005 | H3N2 | USA | 7 | 1.20 | 1.1–1.3 | Effective | Laboratory confirmed illness | [119] | 2008 |
2006–2007 | H3N2 | Israel | 3 | 1.28 |  | Effective | Unconfirmed illness | [112] | 2011 |
2006–2007 | H3N2 | Israel | 3 | 1.33 |  | Effective | Unconfirmed illness | [112] | 2011 |
2007–2008 | H3N2 | Israel | 3 | 1.25 |  | Effective | Unconfirmed illness | [112] | 2011 |
2007–2008 | H3N2 | Israel | 3 | 1.29 |  | Effective | Unconfirmed illness | [112] | 2011 |
2011/12 | H1N1 | Mexico | 3 | 1.20 | Â | Effective | Laboratory confirmed hospitalizations | [120] | 2012 |
2011/12 | H1N1 | Mexico | 3 | 1.20 | Â | Effective | Laboratory confirmed hospitalizations | [121] | 2012 |
2011/12 | H1N1 | Mexico | 4 | 1.30 | Â | Effective | Laboratory confirmed hospitalizations | [121] | 2012 |
Median reproduction number for seasonal influenza: 1.28; Interquartile range 1.19–1.37 |